1 Prediction of outcome of patients with metastatic breast cancer: evaluation with prognostic factors and Nottingham prognostic index

2 Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins

3 Safety and efficacy following 10-years of overnight orthokeratology for myopia control

4 Risk of losing remission, low disease activity or radiographic progression in case of bDMARD discontinuation or tapering in rheumatoid arthritis: systematic analysis of the literature and meta-analysis

5 Likely health outcomes for untreated acute febrile illness in the tropics in decision and economic models; a Delphi survey

6 Dietary restriction and glucose regulation in aging rhesus monkeys: a follow-up report at 8.5 yr

7 Inflammatory colonic carcinogenesis: a review on pathogenesis and immunosurveillance mechanisms in ulcerative colitis

8 Visual function and quality of life following vitrectomy and epiretinal membrane peel surgery

9 Five-year cumulative incidence and progression of epiretinal membranes: the Blue Mountains Eye Study

10 CD4 and total lymphocyte counts as predictors of HIV disease progression

11 The role of HSV in the transmission and progression of HIV

12 Effect of spectacle lenses designed to reduce relative peripheral hyperopia on myopia progression in Japanese children: a 2-year multicenter randomized controlled trial

13 Use of total lymphocyte count for monitoring response to antiretroviral therapy

14 Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States

15 Applying Data Warehousing to a Phase III Clinical Trial From the Fondazione Italiana Linfomi Ensures Superior Data Quality and Improved Assessment of Clinical Outcomes

16 Prospective assessment of cardiovascular risk parameters in patients with rheumatoid arthritis

17 An Antibody Designed to Improve Adoptive NK-Cell Therapy Inhibits Pancreatic Cancer Progression in a Murine Model

18 Cytomegalovirus infection and HIV-1 disease progression in infants born to HIV-1-infected women. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection Study Group

19 Evaluation of human immunodeficiency virus (HIV) type 1 RNA levels in cerebrospinal fluid and viral resistance to zidovudine in children with HIV encephalopathy

20 Predictors of immunologic long-term nonprogression in HIV-infected children: implications for initiating therapy

21 Encephalopathy and progression of human immunodeficiency virus disease in a cohort of children with perinatally acquired human immunodeficiency virus infection. Women and Infants Transmission Study Group

22 Immunophenotypic analysis of HIV-infected children: alterations within the first year of life, changes with disease progression, and longitudinal analyses of lymphocyte subsets

23 Clonal dominance patterns of CD8 T cells in relation to disease progression in HIV-infected children

24 Changing Crohn's disease management: need for new goals and indices to prevent disability and improve quality of life

25 Normative estimates of cross-sectional and longitudinal brain volume decline in aging and AD

26 Induction of specific T-cell responses in HIV infection

27 Analysis of Wnt gene expression in prostate cancer: mutual inhibition by WNT11 and the androgen receptor

28 Prostate tumor progression is mediated by a paracrine TGF-beta/Wnt3a signaling axis

29 Dickkopf-1 expression increases early in prostate cancer development and decreases during progression from primary tumor to metastasis

30 Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group

31 Distal tibial tubercle osteotomy is superior to the proximal one for progression of patellofemoral osteoarthritis in medial opening wedge high tibial osteotomy

32 Gingival inflammation and subgingival calculus as determinants of disease progression in early-onset periodontitis

33 Early and tight glycaemic control - the key to managing type 2 diabetes

34 Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial

35 The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes

36 Distal tuberosity osteotomy in open-wedge high tibial osteotomy does not exacerbate patellofemoral osteoarthritis on arthroscopic evaluation

37 PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer

38 Gingivitis as a risk factor in periodontal disease

39 Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus

40 Augmented intelligence with natural language processing applied to electronic health records for identifying patients with non-alcoholic fatty liver disease at risk for disease progression.

41 Effects of low-dose aspirin on clinical outcome and disease progression in patients with gastroenteropancreatic neuroendocrine neoplasm.

42 Association between metformin use and disease progression in obese people with knee osteoarthritis: data from the Osteoarthritis Initiative—a prospective cohort study

43 [Enhancing monitoring of disease progression-remote sensoring in multiple sclerosis].

44 A single systemic inflammatory insult causes acute motor deficits and accelerates disease progression in a mouse model of human tauopathy.

45 Effects of gene mutation and disease progression on representative neural circuits in familial Alzheimer's disease.

46 Neuropsychiatric Correlates of Small Vessel Disease Progression in Incident Cognitive Decline: Independent and Interactive Effects.

47 Scores of Health-Related Quality of Life Questionnaire Worsen Consistently in Patients of COPD: Estimating Disease Progression over 30 Years by SReFT with Individual Data Collected in SUMMIT Trial

48 CD4 and total lymphocyte counts as predictors of HIV disease progression

49 new insights about treg and th17 cells in hiv infection and disease progression

50 age and environment influences on mouse prion disease progression: behavioral changes and morphometry and stereology of hippocampal astrocytes

51 change in content of multiple cytokines in the serum of mods mice and its relationship with disease progression

52 cellular transplantation alters the disease progression in becker’s muscular dystrophy

53 parkinson’s disease progression: implicit acquisition, cognitive and motor impairments, and medication effects

54 a pilot trial of pioglitazone hcl and tretinoin in als: cerebrospinal fluid biomarkers to monitor drug efficacy and predict rate of disease progression

55 circadian rhythm dysfunction accelerates disease progression in a mouse model with amyotrophic lateral sclerosis

56 interstitial fluid flow in cancer: implications for disease progression and treatment

57 association between angiogenesis soluble factors and disease progression markers in chronic hepatitis c patients asociación entre factores angiogénicos solubles y marcadores de progresión de la enfermedad en pacientes con hepatitis crónica c

58 rapid disease progression of liver metastases following resection in a liver-transplanted patient with probable lynch syndrome – a case report and review of the literature

59 the angiogenic activity of ascites in the course of ovarian cancer as a marker of disease progression

60 changes in b-cell counts and percentages during primary hiv infection associated with disease progression in hiv-infected men who have sex with men: a preliminary study

61 blood transcriptional signatures for disease progression in a rat model of osteoarthritis

62 non-monotonic reorganization of brain networks with alzheimer’s disease progression

63 extracellular vesicles as modulators of tumor microenvironment and disease progression in glioma

64 etiology and pediatric chronic kidney disease progression: taiwan pediatric renal collaborative study

65 Micronutrients and Human Immunodeficiency Virus Type 1 Disease Progression among Adults and Children

66 Postradiation imaging changes in the CNS: how can we differentiate between treatment effect and disease progression?

67 A Convolutional Neural Network Approach to Quantify Lung Disease Progression in Patients with Fibrotic Hypersensitivity Pneumonitis (HP).

68 Determinants of lung disease progression measured by lung clearance index in children with cystic fibrosis.

69 Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

70 Endotoxin Activity Assay as a Novel Predictor of Disease Progression in Patients With Mild Cholangitis.

Keyword Connections

Journals

Research Groups

Bibliographies